04.28.26 -- Target Selection Drives The Future Of CAR-T Therapy In Solid Tumors

Achieve scalable MSC manufacturing by implementing closed systems and modular scale-out strategies that minimize contamination risks and ensure consistent cellular stability and efficacy.

Enhance AAV yield and quality through engineered Rep-Cap plasmids. This next-generation approach addresses core manufacturing hurdles to provide a more scalable solution for viral vector therapy.

Tangential Flow Depth Filtration (TFDF) intensifies virus production by streamlining the clarification process. Boost efficiency and yield for both LV and AAV manufacturing with this methodology.

Peptones address critical manufacturing challenges by boosting cell culture performance. Improve yields and lower overall production costs by integrating these components into your bioprocess.

Learn how to separate molecules strictly by size, effectively remove salts, and select the correct pore specifications for a gentle, non-destructive purification workflow.

Discover a reliable solution for labeling small batches of medical products, including vials, syringes, and cartridges, that fully automatic machines struggle to handle.

Reach metabolic stability and consistent growth in cell therapy applications. Research highlights successful hADSC expansion using microcarriers within scalable stirred-tank bioreactors.

Consolidate cell clearance and sterile filtration into a single device. This approach simplifies the clarification of CHO-cells and other mammalian cultures for more efficient downstream work.

Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and see how this technology is revolutionizing healthcare for the future and beyond.